Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • telemedicine

    Healthcare setting

    Clinical research in 2026: The trends shaping tomorrow

    Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.

    Cuttsy + Cuttsy

    - PMLiVE

    Lilly and Indiana University collaborate to expand clinical trial access

    The five-year agreement includes a focus on R&D for Alzheimer’s disease

    - PMLiVE

    Kymera reports positive results in clinical trial for atopic dermatitis

    KT-621 could become a first-in-class, once-a-day oral treatment

    - PMLiVE

    Roche’s Columvi improves survival in large B-cell lymphoma

    Approximately 160,000 people are diagnosed with this aggressive form of cancer each year

    - PMLiVE

    Novo Nordisk presents new findings on semaglutide in Alzheimer’s disease

    While the trials did not meet their primary endpoints, they highlighted important biomarker findings

    - PMLiVE

    Vandria announces positive phase 1 data for Alzheimer’s treatment

    Trial data showed that VNA-318 has the ability to penetrate the brain

    - PMLiVE

    5 key digital CX challenges in pharma, and how to start solving them

    Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...

    Graphite Digital

    Printed version of 'The participation equation'

    Behind the scenes: why we created ‘The participation equation’

    Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.

    Cuttsy + Cuttsy

    R:SQD logo

    Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

    Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

    Cuttsy + Cuttsy

    - PMLiVE

    Aqilion announces positive results from eosinophilic esophagitis treatment study

    Phase 2 trials for EoE are now expected to be initiated in Europe, Canada and the US

    Report fan imager

    New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

    Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

    Cuttsy + Cuttsy

    - PMLiVE

    AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

    Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

    Innovative Trials

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links